Cargando…
Levosimendan. A promising future drug for refractory cardiac failure in children?
Intravenous positive inotropic agents play an important role in treating acute decompensation of patients with heart failure due to left ventricular systolic dysfunction. Levosimendan is a new positive inotropic agent having ATP-dependent potassium-channel opening, and calcium-sensitizing effects, w...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824328/ https://www.ncbi.nlm.nih.gov/pubmed/27056655 http://dx.doi.org/10.1016/j.ihj.2015.09.013 |